This clinical trial evaluates electronic (e)-visits compared to usual treatment for improving chronic obstructive pulmonary disease (COPD) screening and smoking cessation among patients seen in rural health clinics. More than 16 million Americans have COPD and millions more suffer from COPD but have not yet been diagnosed or treated. COPD is now concentrated within rural communities and those who reside in rural areas have both higher COPD incidence and higher COPD-related death rates. Because COPD is most commonly caused by cigarette smoking, using telehealth e-visits to extend the reach of evidence-based smoking cessation treatment (i.e., medication and counseling) to those at risk of COPD in rural areas may improve early detection of COPD among cigarette smokers. E-visits for COPD screening and smoking cessation may be more effective than usual treatment for improving early diagnosis of COPD, utilization of cessation treatment, and successful smoking cessation.
Study sponsor and potential other locations can be found on ClinicalTrials.gov for NCT06236347.
Locations matching your search criteria
United States
South Carolina
Charleston
Medical University of South CarolinaStatus: Active
Contact: Jennifer Dahne
Phone: 843-876-2280
Florence
MUSC Health Florence Medical CenterStatus: Active
Contact: Jennifer Dahne
Lancaster
MUSC Health Lancaster Medical CenterStatus: Active
Contact: Jennifer Dahne
Mullins
MUSC Health Marion Medical CenterStatus: Active
Contact: Jennifer Dahne
PRIMARY OBJECTIVES:
I. Conduct a stepped-wedge, cluster-randomized clinical trial (N = 144) to examine the effectiveness of the COPD screening and smoking cessation e-visits versus (vs.) treatment as usual (TAU) for smoking cessation across 11 rural (Rural-Urban Commuting Area codes 4-10) primary care practices in South Carolina.
II. Evaluate e-visit implementation outcomes across rural South Carolina primary care settings at patient, provider, and organizational levels.
OUTLINE: Clinics are randomized to 1 of 2 arms.
ARM I: Patients attend a baseline e-visit and undergo smoking history, motivation to quit, and COPD symptom assessments. Patients receive tailored recommendations for cessation medication, a referral to the quitline, and a digital copy of the Clearing the Air booklet. E-visit results are shared with the patient's primary care provider (PCP), the PCP reviews the e-visit results, and may then respond virtually to the patient and prescribe medication as indicated. Patients who are found to be symptomatic for COPD receive a referral for in-person spirometry testing. All patients attend a follow-up e-visit 1 month later to assess progress toward cessation and barriers to quitting.
ARM II: Patients receive treatment as usual, including information about the state quitline, education about quitting, and a recommendation to contact their PCP to discuss cessation.
After completion of study intervention, patients are followed up at 1, 3, and 6 months.
Trial PhaseNo phase specified
Trial Typescreening
Lead OrganizationMedical University of South Carolina
Principal InvestigatorJennifer Dahne
